Heart-Lung machine could be lifeline for riskiest valve patients
NCT ID NCT07309029
Summary
This study is testing whether using a heart-lung machine (called LAVA-ECMO) before or during a minimally invasive heart valve replacement can make the procedure safer for high-risk patients. The research involves 30 adults with severe aortic valve narrowing who are unstable or have complex heart anatomy. Doctors want to see if this proactive support reduces deaths, cardiac arrests, or emergency surgeries during the hospital stay.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Center for Structural Heart Disease Henry Ford Hospital
RECRUITINGDetroit, Michigan, 48202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Valve and Structural Heart Center Morristown Medical Center
RECRUITINGMorristown, New Jersey, 07960, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.